In Vitro Diagnostics Program
Early Disease Detection & Patient Stratification
Research/DiscoveryActive
Key Facts
Indication
Early Disease Detection & Patient Stratification
Phase
Research/Discovery
Status
Active
Company
About BioLum Sciences
BioLum Sciences is a private, preclinical-stage company developing a proprietary chemiluminescence platform for sensitive biomarker detection in drug discovery and diagnostics. Its core business involves providing custom assay development and high-throughput screening services to pharmaceutical partners, while also building a pipeline of its own chemiluminescence kits aimed at eventual translation into in vitro diagnostics. The company targets major disease areas including cardiovascular, neurologic, respiratory, and pain & inflammation disorders, positioning itself at the intersection of precision medicine and proactive healthcare.
View full company profile